GFM
ORKA

GF Fund Management’s Oruka Therapeutics ORKA Stock Holding History

GF Fund Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
1,192
+105
+10% +$7K ﹤0.01% 321
2026
Q1 		$53.3K Buy
1,087
+137
+14% +$4.76K ﹤0.01% 391
2025
Q4 		$28.8K Buy
950
+144
+18% +$4.01K ﹤0.01% 467
2025
Q3 		$15.5K Sell
806
-90
-10% -$1.33K ﹤0.01% 521
2025
Q2 		$10K Hold
896
– – ﹤0.01% 569
2025
Q1 		$9.19K Buy
896
+161
+22% +$2.01K ﹤0.01% 576
2024
Q4 		$14.3K Buy
+735
New +$17.9K ﹤0.01% 504

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GF Fund Management's ORKA Position: Q2 2026 in Review

GF Fund Management increased its Oruka Therapeutics (ORKA) stake by 9.7% in Q2 2026, buying an estimated $7K and bringing the position to 1,192 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #321.

GF Fund Management first reported a position in ORKA in Q4 2024 and has held it in 7 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • GF Fund Management held 1,192 shares of Oruka Therapeutics worth $113K as of Q2 2026.
  • GF Fund Management bought 105 Oruka Therapeutics shares in Q2 2026, an estimated $7K.
  • Oruka Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #321 holding.
  • GF Fund Management first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.